EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical performance of 3 commercially available point-of-care antibody tests for Brucella canis in dogs

Callum Atkins, Megan Madden, Shauni Emanuel, Ioannis Oikonomidis iD, Rebecca Franklin-Guild, Cassandra Guarino, Glynn Woods

Journal of Veterinary Internal Medicine · 02.03.2026 · 40 (2)

DOI: 10.1093/jvimsj/aalag073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 30.04.2026. Verfasst von Callum Atkins und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin, Edinburgh, EH25 9RG, United Kingdom. Hauptthemen laut MEDLINE: Brucellosis, Dog Diseases, Brucella canis, Antibodies, Bacterial. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital for Small Animals Small Grants program, University of Edinburgh.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brucellosis in dogs, caused by Brucella canis, is a zoonotic disease often underdiagnosed because of diagnostic challenges and subclinical infection. Bacterial culture, the reference standard, is impractical and has limited sensitivity because of intermittent or low-grade bacteremia. Accurate point-of-care (POC) testing could facilitate timely management and infection control. Hypothesis/Objectives Evaluate the diagnostic performance of 3 POC lateral flow assays for detection of B. canis antibodies in dogs, using the Canine Brucella Multiplex (CBM) assay as the reference serologic assay. Animals Fifty serum samples from 50 client-owned dogs submitted for B. canis serology.

Methods

Samples were classified as CBM-positive (n = 10; culture-positive dogs) or CBM-negative (n = 40; healthy dogs undergoing export testing). Assays were run in duplicate and independently interpreted by 2 observers. Positive percent agreement (PPA), negative percent agreement (NPA), and inter-reader agreement were calculated relative to CBM.

Results

The Anigen Rapid C.Brucella Ab assay demonstrated 90.0% PPA (95% CI, 55.5-99.8) and 100% NPA (95% CI, 91.1-100). The FASTest® BRUCELLA canis assay demonstrated 100% PPA (95% CI, 69.1-100) and 92.5% NPA (95% CI, 79.6-98.4). The Canine Brucella LPS Antibody Rapid Test demonstrated 0% PPA (95% CI, 0-30.9) and 97.5% NPA (95% CI, 86.8-99.9). Inter-reader agreement was almost perfect for all assays (κ = 0.81-1.00). Conclusions and clinical importance The Anigen Rapid C.Brucella Ab and FASTest® BRUCELLA canis assays showed good agreement with the CBM assay and may be useful rule out tests in dogs with clinical signs compatible with brucellosis. In low prevalence settings, positive results require confirmatory testing, and false negatives remain possible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrucellosisDog DiseasesBrucella canisAntibodies, BacterialAnimalsDogsSensitivity and SpecificityFemaleRapid Diagnostic TestsSerologic TestsPoint-of-Care SystemsMale

Stichwörter der Autor:innen

Brucella caniscanine brucellosisdiagnostic accuracylateral flow assayzoonotic disease

Substanzen

Antibodies, Bacterial

Autor:innen und Institutionen

  • Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin, Edinburgh, EH25 9RG, United Kingdom.
  • Department of Veterinary Anatomy, Physiology and Pathology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Leahurst Campus, Liverpool, CH64 7TE, United Kingdom.
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, United States.
  • William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California Davis, Davis, CA 95616, United States.

ORCID-Profile: Ioannis Oikonomidis

Förderung

  • Hospital for Small Animals Small Grants program
  • University of Edinburgh

Zitieren

APA

Atkins, C., Madden, M., Emanuel, S., Oikonomidis, I., Franklin-Guild, R., Guarino, C., & Woods, G. (2026). Clinical performance of 3 commercially available point-of-care antibody tests for Brucella canis in dogs. Journal of Veterinary Internal Medicine, 40(2). https://doi.org/10.1093/jvimsj/aalag073

Vancouver

Atkins C, Madden M, Emanuel S, Oikonomidis I, Franklin-Guild R, Guarino C, et al. Clinical performance of 3 commercially available point-of-care antibody tests for Brucella canis in dogs. Journal of Veterinary Internal Medicine. 2026;40(2). doi:10.1093/jvimsj/aalag073

BibTeX
@article{Atkins2026,
  author = {Atkins, Callum and Madden, Megan and Emanuel, Shauni and Oikonomidis, Ioannis and Franklin-Guild, Rebecca and Guarino, Cassandra and Woods, Glynn},
  title = {Clinical performance of 3 commercially available point-of-care antibody tests for Brucella canis in dogs},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2026},
  volume = {40},
  number = {2},
  doi = {10.1093/jvimsj/aalag073}
}
Kostenlos starten →